Table 1.
Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
---|---|---|---|---|---|
Neeraj Agarwal, MD | None | None | None | None | 8/3/12 |
Matthew C. Biagioli, MD, MS | None | None | None | None | 10/16/12 |
Peter E. Clark, MD | None | Archimedes Pharma Ltd. | None | None | 8/28/12 |
Mario A. Eisenberger, MD | Bristol-Myers Squibb Company; Genentech, Inc.; Agensys, Inc.; and sanofi-aventis U.S. LLC | Ipsen | None | None | 8/31/12 |
Richard E. Greenberg, MD | None | Endo Pharmaceuticals Inc. | None | None | 3/26/13 |
Harry W. Herr, MD | None | None | None | None | 8/28/12 |
Brant A. Inman, MD, MSc | GlaxoSmithKline plc | None | None | None | 8/28/12 |
Deborah A. Kuban, MD | None | None | Immtech International, Inc. | None | 8/28/12 |
Timothy M. Kuzel, MD | Bayer AG; Bristol-Myers Squibb Company; CureTech; Eli Lilly and Company; GlaxoSmithKline; Merck & Co., Inc.; Novartis AG; Onyx Pharmaceuticals, Inc.; Alton Pharma, Inc.; Argos Therapeutics, Inc.; and Biovex Group, Inc. | Celgene Corporation; Exelixis Inc.; Genentech, Inc.; GlaxoSmithKline plc; Jannsen Pharmaceuticals, Inc.; Novartis AG; Onyx Pharmaceuticals, Inc.; Affymax, Inc.; AVEO Pharmaceuticals, Inc.; and Prometheus Laboratories Inc. | None | None | 8/28/12 |
Subodh M. Lele, MD | None | None | None | None | 8/28/12 |
Jeff Michalski, MD, MBA | None | None | None | None | 8/13/12 |
Lance C. Pagliaro, MD | None | None | None | None | 1/4/13 |
Sumanta K. Pal, MD | None | Genentech, Inc.; GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; and sanofi-aventis U.S. LLC | None | None | 3/27/12 |
Anthony Patterson, MD | None | None | None | None | 8/15/12 |
Elizabeth R. Plimack, MD, MS | None | Amgen Inc. | None | None | 10/17/12 |
Kamal S. Pohar, MD | None | None | None | None | 9/27/12 |
Michael P. Porter, MD, MS | None | None | None | None | 4/25/12 |
Jerome P. Richie, MD | None | None | None | None | 5/2/12 |
Wade J. Sexton, MD | Endo Pharmaceuticals Inc. | Endo Pharmaceuticals | None | None | 8/3/12 |
William U. Shipley, MD | None | None | Pfizer Inc. | None | 8/28/12 |
Eric J. Small, MD | None | Dendreon Corporation | None | None | 9/24/12 |
Philippe E. Spiess, MD, MS | None | None | None | None | 5/4/12 |
Donald L. Trump, MD | None | None | None | None | 5/17/12 |
Geoffrey Wile, MD | None | None | None | None | 6/13/12 |
Timothy G. Wilson, MD | None | Covidien | None | None | 1/6/12 |
The NCCN guidelines staff have no conflicts to disclose.